• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Insmed Incorporated - Common Stock (NQ:INSM)

    189.60 -4.62 (-2.38%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Insmed Incorporated - Common Stock

    < Previous 1 2 3 4 5 6 7 Next >
    Analysts and Executives Converge February 2nd at the 30th Annual Emerald Groundhog Day Investment Forum
    From Emerald Asset Management PA, LLC
    Via Business Wire
    Barclays Maintains Overweight Rating for Insmed: Here's What You Need To Know
     
    Via Benzinga
    Analyst Expectations for Insmed's Future
     
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
    This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
    Via Benzinga
    Analyst Ratings for Insmed
     
    Via Benzinga
    What 4 Analyst Ratings Have To Say About Insmed
     
    Via Benzinga
    Why Insmed's Shares Fell 14.7% on Wednesday
    The biotech company is raising money to help it launch another drug, but it's diluting current shareholders in the process. 
    Via The Motley Fool
    Insmed's Return On Capital Employed Insights
      
    Via Benzinga
    Why Aptevo Therapeutics Shares Are Trading Higher By More Than 100%; Here Are 28 Stocks Moving Premarket
    Gainers 
    Via Benzinga
    Coupa Software, Horizon Therapeutics And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
    U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
    Upgrades 
    Via Benzinga
    Insmed: Q1 Earnings Insights
    Insmed (NASDAQ:INSM) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Insmed: Q4 Earnings Insights
      Insmed (NASDAQ:INSM) reported its Q4 earnings results on Thursday, February 17, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Insmed's Return On Capital Employed Overview
    Benzinga Pro data, Insmed (NASDAQ:INSM) reported Q3 sales of $67.73 million. Earnings fell to a loss of $131.15 million, resulting in a 37.12% decrease from last quarter. 
    Via Benzinga
    $1.4 Million Bet On This Real Estate Stock? 3 Stocks Insiders Are Buying
    Although US stocks closed lower on Wednesday, there were a few notable insider trades. 
    Via Benzinga
    Insmed: Q3 Earnings Insights
    Insmed (NASDAQ:INSM) reported its Q3 earnings results on Thursday, October 27, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Insmed missed estimated earnings by... 
    Via Benzinga
    iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday
    U.S. stocks closed mixed on Friday following the release of jobs data for July. Here is the list of some big stocks moving higher in the previous session. 
    Via Benzinga
    Earnings Scheduled For February 17, 2022
    Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. 
    Via Benzinga
    Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
    Gainers Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of... 
    Via Benzinga
    Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session
    Gainers SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share. 
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
    This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
    Via Benzinga
    Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
    U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session. 
    Via Benzinga
    Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
    Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share... 
    Via Benzinga
    Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
    Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday. 
    Via Benzinga
    Insmed's Return On Capital Employed Overview
    According to data from Benzinga Pro, during Q1, Insmed's (NASDAQ:INSM) reported sales totaled $53.11 million. Despite a 16.25% increase in earnings, the company posted a loss of $94.62 million. 
    Via Benzinga
    How To Attend Insmed Q1 2022 Earnings Conference Call
    Insmed (NASDAQ:INSM) will host a conference call at 08:30 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. How to Attend Insmed (INSM) Conference Call Follow this link to access the live... 
    Via Benzinga
    Insmed's Return On Capital Employed Insights
    Insmed (NASDAQ:INSM) brought in sales totaling $56.12 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 0.23%, resulting in a loss of $112.98 million. 
    Via Benzinga
    The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel... 
    Via Benzinga
    The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
    Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
    Upgrades According to TD Securities, the prior rating for MAG Silver Corp (AMEX: 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.